白内障手术与老年女性死亡率的相关性:妇女健康倡议研究结果
基于妇女健康倡议(WHI)与医疗保险理赔数据库链接的前瞻性队列研究,纳入74 044名65岁及以上白内障女性,其中41 735例行白内障手术。调整协变量后,白内障手术与较低的全因死亡率(AHR 0.40;95%CI 0.39-0.42)及血管性、癌症、意外、神经性、肺部和感染性死因死亡率较低相关。作者指出该关联是否由白内障手术本身解释尚不明确,需进一步研究。
要点
- 老年白内障女性中,白内障手术与较低全因死亡率相关(AHR 0.40;95%CI 0.39-0.42)。
- 白内障手术与血管性、癌症、意外、神经性、肺部和感染性死因死亡率较低相关。
- 作者认为该关联是否由白内障手术本身解释尚不明确,需进一步研究。
核心结论
- 在WHI的老年白内障女性中,白内障手术与较低的全因及特定死因死亡率相关,但该关联是否由白内障手术本身解释尚不明确。
- 作者认为进一步研究白内障手术、系统性疾病与疾病相关死亡率的相互作用将有助于改善患者照护。
研究设计与样本
- 前瞻性队列研究,数据来自妇女健康倡议(WHI)临床试验和观察性研究,并与医疗保险理赔数据库链接。
- 纳入65岁及以上、在链接的医疗保险理赔数据库中诊断为白内障的女性,共74 044人,其中41 735人接受白内障手术。
- WHI数据收集时间为1993年1月1日至2015年12月31日;本研究数据分析时间为2014年7月1日至2017年9月1日。
主要发现
- 研究对象平均(SD)年龄为70.5(4.6)岁;最常见的族裔为白人(64 430人[87.0%]),其次为黑人(5293人[7.1%])和西班牙裔(1723人[2.3%])。
- 两组的死亡率均为2.56/100人年。
- 在协变量调整的Cox模型中,白内障手术与较低的全因死亡率相关(AHR 0.40;95%CI 0.39-0.42)。
- 白内障手术与较低的血管性(AHR 0.42;95%CI 0.39-0.46)、癌症(AHR 0.31;95%CI 0.29-0.34)、意外(AHR 0.44;95%CI 0.33-0.58)、神经性(AHR 0.43;95%CI 0.36-0.53)、肺部(AHR 0.63;95%CI 0.52-0.78)和感染性疾病(AHR 0.44;95%CI 0.36-0.54)死亡率相关。
关键数值与推荐
- 暴露定义为医疗保险理赔代码确定的白内障手术。
- 主要结局包括全因死亡率以及归因于血管性、癌症、意外、神经性、肺部和感染性原因的死亡率。
- 使用log-rank检验和Cox比例风险回归模型比较死亡率,模型调整人口学特征、系统性和眼部合并症、吸烟、饮酒、体重指数和体力活动。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出该关联是否由白内障手术本身解释尚不明确。
- 作者认为需进一步研究白内障手术、系统性疾病与疾病相关死亡率的相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Previous studies have suggested an association between cataract surgery and decreased risk for all-cause mortality potentially through a mechanism of improved health status and functional independence, but the association between cataract surgery and cause-specific mortality has not been previously studied and is not well understood. OBJECTIVE: To examine the association between cataract surgery and total and cause-specific mortality in older women with cataract. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study included nationwide data collected from the Women's Health Initiative (WHI) clinical trial and observational study linked with the Medicare claims database. Participants in the present study were 65 years or older with a diagnosis of cataract in the linked Medicare claims database. The WHI data were collected from January 1, 1993, through December 31, 2015. Data were analyzed for the present study from July 1, 2014, through September 1, 2017. EXPOSURES: Cataract surgery as determined by Medicare claims codes. MAIN OUTCOMES AND MEASURES: The outcomes of interest included all-cause mortality and mortality attributed to vascular, cancer, accidental, neurologic, pulmonary, and infectious causes. Mortality rates were compared by cataract surgery status using the log-rank test and Cox proportional hazards regression models adjusting for demographics, systemic and ocular comorbidities, smoking, alcohol use, body mass index, and physical activity. RESULTS: A total of 74 044 women with cataract in the WHI included 41 735 who underwent cataract surgery. Mean (SD) age was 70.5 (4.6) years; the most common ethnicity was white (64 430 [87.0%]), followed by black (5293 [7.1%]) and Hispanic (1723 [2.3%]). The mortality rate was 2.56 per 100 person-years in both groups. In covariate-adjusted Cox models, cataract surgery was associated with lower all-cause mortality (adjusted hazards ratio [AHR], 0.40; 95% CI, 0.39-0.42) as well as lower mortality specific to vascular (AHR, 0.42; 95% CI, 0.39-0.46), cancer (AHR, 0.31; 95% CI, 0.29-0.34), accidental (AHR, 0.44; 95% CI, 0.33-0.58), neurologic (AHR, 0.43; 95% CI, 0.36-0.53), pulmonary (AHR, 0.63; 95% CI, 0.52-0.78), and infectious (AHR, 0.44; 95% CI, 0.36-0.54) diseases. CONCLUSIONS AND RELEVANCE: In older women with cataract in the WHI, cataract surgery is associated with lower risk for total and cause-specific mortality, although whether this association is explained by the intervention of cataract surgery is unclear. Further study of the interplay of cataract surgery, systemic disease, and disease-related mortality would be informative for improved patient care.
引用
- Tseng VL, Chlebowski RT, Yu F, et al. Association of Cataract Surgery With Mortality in Older Women: Findings from the Women's Health Initiative. JAMA Ophthalmol. 2018. PMID: 29075781. doi:10.1001/jamaophthalmol.2017.4512
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。